医療における人工知能の世界市場2020-2040

◆英語タイトル:GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FORECAST 2020-2028
◆商品コード:INK20MY013
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年4月
◆ページ数:205
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは医療における人工知能の世界市場について調査・分析し、調査範囲・手法、エグゼクティブサマリー、市場動向、主要分析、提供別(ディープラーニング、クエリメソッド、自然言語処理、コンテキストアウェア処理)分析、エンドユーザー別(ACOS及びMCOS、患者、納付者、製薬及びバイオテクノロジー企業、供給者)分析、用途別(リアルタイムモニタリング、精密医療、パーソナルヘルス・看護補助、ロボット支援下手術、供給者、その他)分析、地域別分析、企業情報などの情報をお届けいたします。
・調査範囲・手法
・エグゼクティブサマリー
・市場動向
・主要分析
・医療における人工知能世界市場:提供別(ディープラーニング、クエリメソッド、自然言語処理、コンテキストアウェア処理)
・医療における人工知能世界市場:エンドユーザー別(ACOS及びMCOS、患者、納付者、製薬及びバイオテクノロジー企業、供給者)
・医療における人工知能世界市場:用途別(リアルタイムモニタリング、精密医療、パーソナルヘルス・看護補助、ロボット支援下手術、供給者、その他)
・地域別分析
・企業情報
【レポートの概要】

KEY FINDINGS
The global artificial intelligence in healthcare market is set to register growth, projecting a CAGR of 38.05% during the forecast period, 2020-2028. The prominent drivers of market growth are estimated to be the rising big data in the healthcare industry, the growing use of AI in genetics, the emergence of personalized medicine in tests for clinical decision making, along with the creation of a real-time monitoring system due to AI.

MARKET INSIGHTS
The utilization of AI in healthcare entails the use of software and algorithms for estimating the human perception for analyzing complex medical data, along with the relationship between treatments or prevention techniques and patient outcomes. The growing demand for real-time monitoring system is one of the key aspects propelling the growth of the global artificial intelligence in healthcare market. The real-time monitoring devices like health monitoring devices or indicators track real-time health data of patients, which is increasing the demand for AI in healthcare. The devices also drive the relevancy of data interpretation and aid in reducing the time the patients spend in piecing data output. In healthcare, the devices help in detecting and preventing undesirable patient outputs. The growing number of mobile devices integrated with artificial intelligence assists in the prediction of future outcomes with regard to health, which further benefits market growth.
Medical practitioners are reluctant to adopt AI-based technologies, and this is restraining the growth of the market. The reluctance is because of the lack of data that identifies healthcare decisions. Also, from a diagnostics point of view, AI systems fare less in terms of efficiency in comparison to conventional methods. The companies in the market are competing against each other by providing the same characteristics and similar prices. The competitive rivalry is projected to be high during the forecast period.

REGIONAL INSIGHTS
The geographical segmentation of the global artificial intelligence in healthcare market includes the analysis of Europe, North America, Asia Pacific, and the rest of the world. Inkwood Research estimates the Asia Pacific region to be the fastest-growing region by the end of the forecast period. The invention of new technologies, the presence of countries like China, Japan, Australia, and India, and the thriving artificial intelligence market, are the factors propelling the growth of the market.

COMPETITIVE INSIGHTS
Some of the prominent companies operating in the market are Enlitic Inc, Next IT Corporation, Recursion, Welltok, GE Healthcare, Microsoft Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. DEVELOPMENT OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
3.2. MARKET DEFINITION
3.3. KEY DRIVERS
3.3.1. RISE OF BIG DATA IN HEALTHCARE INDUSTRY
3.3.2. EMERGENCE OF PERSONALIZED MEDICINE IN TESTS FOR CLINICAL DECISION MAKING
3.3.3. INCREASING USE OF AI IN GENETICS
3.3.4. AI CREATING A REAL-TIME MONITORING SYSTEM
3.3.5. HEALTHCARE WEARABLES PLAYING AN IMPORTANT ROLE IN MONITORING
3.4. KEY RESTRAINTS
3.4.1. SLOW ADOPTION OF AI BASED TECHNOLOGIES
3.4.2. AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
3.4.3. CHALLENGE TO MAINTAIN DATA SECURITY
3.4.4. LACK OF USABLE DATA IN HEALTHCARE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. VALUE CHAIN ANALYSIS
4.5.1. DATA WAREHOUSE
4.5.2. ARTIFICIAL INTELLIGENCE (AI) ANALYSIS
4.5.3. SOFTWARE DEVELOPMENT
4.6. KEY BUYING CRITERIA
4.6.1. APPLICATION
4.6.2. TECHNOLOGY
4.6.3. INTEGRATION WITH EXISTING INFRASTRUCTURE
4.7. REGULATORY FRAMEWORK
5. MARKET BY OFFERINGS
5.1. HARDWARE
5.2. SOFTWARE
5.3. SERVICES
6. MARKET BY TECHNOLOGY
6.1. DEEP LEARNING
6.2. QUERYING METHOD
6.3. NATURAL LANGUAGE PROCESSING
6.4. CONTEXT AWARE PROCESSING
7. MARKET BY END-USER
7.1. ACOS AND MCOS
7.2. PATIENTS
7.3. PAYERS
7.4. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
7.5. PROVIDERS
8. MARKET BY APPLICATION
8.1. REAL-TIME MONITORING
8.2. PRECISION MEDICINE
8.3. PERSONAL HEALTH AND NURSING ASSISTANTS
8.4. DRUG DEVELOPMENT AND DISCOVERY
8.5. ROBOT-ASSISTED SURGERY
8.6. ADMINISTRATIVE WORKFLOW ASSISTANCE
8.7. CLINICAL TRIALS
8.8. DIAGNOSTIC AND CLINICAL DECISION SUPPORT
8.9. OTHERS
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. UNITED STATES
9.1.2. CANADA
9.2. EUROPE
9.2.1. UNITED KINGDOM
9.2.2. GERMANY
9.2.3. FRANCE
9.2.4. ITALY
9.2.5. RUSSIA
9.2.6. BELGIUM
9.2.7. POLAND
9.2.8. REST OF EUROPE
9.3. ASIA PACIFIC
9.3.1. CHINA
9.3.2. JAPAN
9.3.3. INDIA
9.3.4. SOUTH KOREA
9.3.5. INDONESIA
9.3.6. THAILAND
9.3.7. VIETNAM
9.3.8. AUSTRALIA & NEW ZEALAND
9.3.9. REST OF ASIA PACIFIC
9.4. REST OF WORLD
9.4.1. LATIN AMERICA
9.4.2. MIDDLE EAST & AFRICA
10. COMPANY PROFILES
10.1. DEEP GENOMICS INC
10.2. ENLITIC INC
10.3. GE HEALTHCARE
10.4. GENERAL VISION INC
10.5. GOOGLE
10.6. IBM CORPORATION
10.7. ICARBONX
10.8. INTEL CORPORATION
10.9. MICROSOFT CORPORATION
10.10. NEXT IT CORPORATION
10.11. NVIDIA CORPORATION
10.12. ONCORA MEDICAL
10.13. RECURSION PHARMACEUTICALS INC
10.14. STRYKER CORPORATION
10.15. WELLTOK INC



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医療における人工知能の世界市場2020-2040]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆